Bezjak A

Bezjak A is a prominent researcher in Radiation Oncology, with significant contributions to Lung Cancer treatment methodologies. Their work focuses on Stereotactic Body Radiotherapy (SBRT), Thoracic Radiotherapy, and

• Phase I/II/III Clinical Trials
• Lung Neoplasm Management
• Radiation Toxicity Mitigation

across institutions like NRG Oncology and RTOG.

Recent publications highlight advancements in Ultra-Central Tumor treatment (2024) and Oligoprogressive Cancer interventions (2025). Research trends include

• Dose Optimization
• Interstitial Lung Disease Considerations
• Risk Adaptation in SBRT

as evidenced by collaborations in JAMA Oncology and Int J Radiat Oncol Biol Phys.

Key scientific themes span

• Radiation Physics
• Lung Cancer Survival Analysis
• Clinical Guideline Development

with emphasis on Stereotactic Ablative Radiotherapy and Organ-at-Risk Protection.